These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1197 related articles for article (PubMed ID: 1675189)

  • 1. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
    Takahashi H; Strutton GM; Parsons PG
    Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index.
    Tokuda Y; Mukai K; Matsuno Y; Furuya S; Shimosato Y; Takasaki Y; Saida T; Ishihara K
    Arch Dermatol Res; 1992; 284(6):319-23. PubMed ID: 1363460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study.
    Rieger E; Hofmann-Wellenhof R; Soyer HP; Kofler R; Cerroni L; Smolle J; Kerl H
    J Cutan Pathol; 1993 Jun; 20(3):229-36. PubMed ID: 8103531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related proliferative activity in dermal melanocytic naevi detected by PCNA/cyclin expression.
    Tu P; Miyauchi S; Miki Y
    Br J Dermatol; 1993 Jul; 129(1):65-8. PubMed ID: 8103667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity in Spitz's naevi compared with other melanocytic skin lesions.
    Hofmann-Wellenhof R; Rieger E; Smolle J; Kerl H
    Melanoma Res; 1993 Oct; 3(5):313-7. PubMed ID: 7904841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of proliferating cell nuclear antigen/cyclin in human skin.
    Furukawa F; Imamura S; Fujita M; Kinoshita K; Yoshitake K; Brown WR; Norris DA
    Arch Dermatol Res; 1992; 284(2):86-91. PubMed ID: 1351713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
    Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate.
    Tu P; Miyauchi S; Miki Y
    Am J Dermatopathol; 1993 Aug; 15(4):311-4. PubMed ID: 8105711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth dynamics of acquired melanocytic nevi. Higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi.
    Tokuda Y; Saida T; Mukai K; Takasaki Y
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 1):220-4. PubMed ID: 7913717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen.
    Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1993 Oct; 15(5):441-5. PubMed ID: 7902020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen.
    Soyer HP; Smolle J; Smolle-Juettner FM; Kerl H
    Dermatologica; 1989; 179(1):3-9. PubMed ID: 2569990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigens associated with tumor progression in melanocytic neoplasia.
    Elder DE; Herlyn M
    Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
    White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
    J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative activity of keratinocytes correlates with that of melanocytes in naevi and melanomas.
    Tronnier M; Kämmerer R; Wolff HH
    Arch Dermatol Res; 1995; 287(5):509-11. PubMed ID: 7625864
    [No Abstract]   [Full Text] [Related]  

  • 19. p53 expression is rare in cutaneous melanomas.
    Saenz-Santamaría MC; McNutt NS; Bogdany JK; Shea CR
    Am J Dermatopathol; 1995 Aug; 17(4):344-9. PubMed ID: 8600797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocytic activation in HIV-1 disease: HMB-45 staining in common acquired nevi. Military Medical Consortium for the Advancement of Retroviral Research.
    Smith KJ; Skelton HG; Heimer W; Baxter D; Angritt P; Frisman D; Wagner KF
    J Am Acad Dermatol; 1993 Oct; 29(4):539-44. PubMed ID: 7691905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.